The impact of statins and proton-pump inhibitors on immune checkpoint inhibition in patients with hepatocellular carcinoma

被引：0
|
作者：
Hobeika, B. [1 ]
Philipp, A. B. [1 ]
Piseddu, I. [1 ]
Schondorff, K. [1 ]
Enssle, S. [1 ]
Karin, M. [1 ]
Schneider, J. [1 ]
Reiter, F. P. [2 ]
Geier, A. [2 ]
Mayerle, J. [1 ]
Roessler, D. C. [1 ]
De Toni, E. N. [1 ]
Ben Khaled, N. [1 ]
机构：
[1] Univ Hosp LMU Munich, Dept Med 2, Munich, Germany
[2] Univ Hosp Wurzburg, Div Hepatol, Dept Med 2, Wurzburg, Germany
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.210
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
202P
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
    van Doorn, Diederick J.
    Takkenberg, Robert Bart
    Klumpen, Heinz-Josef
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 23
  • [22] Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma
    Akula, Vinita
    Chen, Lily
    Acikgoz, Yusuf
    Klein, Katherine
    Yavuz, Betul Gok
    Cevik, Lokman
    Demir, Tarik
    Manne, Ashish
    Sahin, Ilyas
    Kaseb, Ahmed
    Hasanov, Elshad
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [23] MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
    Llopiz, Diana
    Silva, Leyre
    Ruiz, Marta
    Castro-Alejos, Carla
    Aparicio, Belen
    Vegas, Lucia
    Infante, Stefany
    Santamaria, Eva
    Sarobe, Pablo
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [24] THE IMPACT OF PROTON-PUMP INHIBITORS ON OUTCOMES FOLLOWING RADICAL PROSTATECTOMY
    Westerman, Mary E.
    Sharma, Vidit
    Kames, R. Jeffrey
    JOURNAL OF UROLOGY, 2016, 195 (04): : E905 - E905
  • [25] Liver injury by immune checkpoint inhibitors in patients with hepatocellular carcinoma.
    Personeni, Nicola
    Pressiani, Tiziana
    Capogreco, Antonio
    Dal Buono, Arianna
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Smiroldo, Valeria
    Bozzarelli, Silvia
    Giordano, Laura
    Aghemo, Alessio
    Santoro, Armando
    Rimassa, Lorenza
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [26] Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
    Ng, Kennedy Yao Yi
    Tan, Sze Huey
    Tan, Jack Jie En
    Tay, Desiree Shu Hui
    Lee, Ailica Wan Xin
    Ang, Andrea Jing Shi
    Wong, Lawrence Wen Jun
    Choo, Su Pin
    Tai, David Wai-Meng
    Lee, Joycelyn Jie Xin
    LIVER CANCER, 2022, 11 (01) : 9 - 21
  • [27] Proton-pump inhibitors: Three of a kind?
    Bateman, DN
    LANCET, 1997, 349 (9066): : 1637 - 1638
  • [28] Safety profile of the proton-pump inhibitors
    Reilly, JP
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 : S11 - S17
  • [29] The proton-pump inhibitors: Similarities and differences
    Horn, J
    CLINICAL THERAPEUTICS, 2000, 22 (03) : 266 - 280
  • [30] THE CONSUMPTION OF PROTON-PUMP INHIBITORS IN SLOVAKIA
    Gatialova, K.
    Bellova, K.
    Foltan, V
    Majtas, J.
    VALUE IN HEALTH, 2012, 15 (07) : A333 - A333
12345